629 related articles for article (PubMed ID: 17760404)
21. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
Ginès P; Arroyo V; Rodés J
Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
[No Abstract] [Full Text] [Related]
22. Treatment of hepatorenal syndrome.
Kiser TH; Maclaren R; Fish DN
Pharmacotherapy; 2009 Oct; 29(10):1196-211. PubMed ID: 19792993
[TBL] [Abstract][Full Text] [Related]
23. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
Cárdenas A
Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis and treatment of hepatorenal syndrome.
Arroyo V; Fernandez J; Ginès P
Semin Liver Dis; 2008 Feb; 28(1):81-95. PubMed ID: 18293279
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in hepatorenal syndrome.
Arroyo V; Torre A; Guevara M
Trop Gastroenterol; 2005; 26(1):13-20. PubMed ID: 15974232
[TBL] [Abstract][Full Text] [Related]
26. [Hepatorenal syndrome].
Pillebout E
Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
[TBL] [Abstract][Full Text] [Related]
27. Hepatorenal syndrome: definition, pathophysiology, clinical features and management.
Bataller R; Sort P; Ginès P; Arroyo V
Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573
[No Abstract] [Full Text] [Related]
28. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
Fagundes C; Ginès P
Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
[TBL] [Abstract][Full Text] [Related]
29. [Renal damage in liver cirrhosis: pathophysiology and management].
Yamamoto T; Hishida A
Nihon Rinsho; 1994 Jan; 52(1):159-64. PubMed ID: 8114286
[TBL] [Abstract][Full Text] [Related]
30. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
31. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
[TBL] [Abstract][Full Text] [Related]
32. Hepatorenal syndrome: new perspectives in pathophysiology and management.
Kes P
Acta Med Croatica; 2000; 54(4-5):165-73. PubMed ID: 11379481
[TBL] [Abstract][Full Text] [Related]
33. Hepatorenal syndrome: emerging perspectives.
Epstein M
Semin Nephrol; 1997 Nov; 17(6):563-75. PubMed ID: 9353866
[TBL] [Abstract][Full Text] [Related]
34. [Hepatorenal syndrome].
Lautrette A; Liotier J; Deteix P; Souweine B
Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
[TBL] [Abstract][Full Text] [Related]
35. Circulatory function and hepatorenal syndrome in cirrhosis.
Ruiz-del-Arbol L; Monescillo A; Arocena C; Valer P; Ginès P; Moreira V; Milicua JM; Jiménez W; Arroyo V
Hepatology; 2005 Aug; 42(2):439-47. PubMed ID: 15977202
[TBL] [Abstract][Full Text] [Related]
36. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
37. Hepatorenal syndrome: pathogenesis and novel pharmacological targets.
Barada K
Curr Opin Pharmacol; 2004 Apr; 4(2):189-97. PubMed ID: 15063365
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of hepatorenal syndrome.
Ginès P
Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
[TBL] [Abstract][Full Text] [Related]
39. New challenge of hepatorenal syndrome: prevention and treatment.
Wong F; Blendis L
Hepatology; 2001 Dec; 34(6):1242-51. PubMed ID: 11732014
[TBL] [Abstract][Full Text] [Related]
40. [Hepatorenal syndrome].
Radziszewski A; Sułowicz W
Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]